A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis-Reference-Cited by-同舟云学术

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis

Published:2020-12 Issue: Volume:14 Page:257-263
ISSN:2211-3207
Container-title:International Journal for Parasitology: Drugs and Drug Resistance
language:en
Short-container-title:International Journal for Parasitology: Drugs and Drug Resistance

Author:

Rodrigues Bruna Côrtes^ORCID,Ferreira Marina Freitas,Barroso Daniel Holanda^ORCID,Motta Jorgeth Oliveira Carneiro da,Paula Carmen Déa Ribeiro de,Porto Cláudia,Martins Sofia Sales,Gomes Ciro Martins,Sampaio Raimunda Nonata Ribeiro

Funder

Federal District Research Support Foundation (FAPDF), Brazil

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Parasitology

Reference35 articles.

1. Plasma antimony determination during cutaneous leishmaniasis treatment with intralesional infiltration of meglumine antimoniate;Aguiar;Trop. Med. Int. Health,2018

2. Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate;Aste;Br. J. Dermatol.,1998

3. Hormone levels are associated with clinical markers and cytokine levels in human localized cutaneous leishmaniasis;Baccan;Brain Behav. Immun.,2011

4. New insights into the developmental biology and transmission mechanisms of Leishmania;Bates;Curr. Mol. Med.,2004

5. Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013);Brahim;Mem. Inst. Oswaldo Cruz,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: The Knowns and the Unknowns;Clinical Infectious Diseases;2023-04-26

2. A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil;Clinical Infectious Diseases;2023-04-26

3. Identification of potential novel inhibitors against glutamine synthetase enzyme of Leishmania major by using computational tools;Journal of Biomolecular Structure and Dynamics;2023-02-06

4. Low doses of 3-phenyl-lawsone or meglumine antimoniate delivery by tattooing route are successful in reducing parasite load in cutaneous lesions of Leishmania (Viannia) braziliensis-infected hamsters;Frontiers in Cellular and Infection Microbiology;2023-01-19

5. Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties;Microbiology Spectrum;2022-12-21